New Agents for the Treatment of Acute Lymphoblastic Leukemia
New Agents for the Treatment of Acute Lymphoblastic Leukaemia (ALL), examines the strategies for the use of new agents as well as possible targets of therapy in this disease. Though associated with high cure rates, relapsed disease has a poor outcome. Moreover, therapy is unduly prolonged and toxic....
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Saha, Vaskar (Επιμελητής έκδοσης), Kearns, Pamela (Επιμελητής έκδοσης) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
New York, NY :
Springer New York,
2011.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Targeted Therapy of Acute Myeloid Leukemia
Έκδοση: (2015) -
Lymphoma and Leukemia of the Nervous System
Έκδοση: (2012) -
Vascular Disruptive Agents for the Treatment of Cancer
Έκδοση: (2010) -
Cytokines in the Genesis and Treatment of Cancer
Έκδοση: (2007) -
Antiangiogenic Agents in Cancer Therapy
Έκδοση: (2008)